Literature DB >> 3157329

Renal response to atrial natriuretic factor in conscious dogs with caval constriction.

R H Freeman, J O Davis, R C Vari.   

Abstract

Constriction of the thoracic inferior vena cava to decrease venous return and atrial filling markedly elevates plasma renin activity (PRA) and plasma aldosterone concentration (PAC) and produces chronic sodium retention and ascites in the dog. Infusion of a synthetic atrial natriuretic factor into conscious dogs with caval constriction and ascites at doses of 175 and 350 ng X kg-1 X min-1 for 30 min each produced striking increases (P less than 0.05) in creatinine clearance, diuresis, and kaliuresis but failed to increase urinary sodium excretion. Infusions of atrial natriuretic factor at these doses into conscious normal dogs, however, produced a striking increase in sodium excretion from 41 +/- 14 and 55 +/- 19 mu eq/min to 150 +/- 58 and 181 +/- 49 mu eq/min (P less than 0.05 for both values). Creatinine clearance and urine flow also increased in these normal dogs, but potassium excretion remained unchanged during the infusion periods. Atrial natriuretic factor produced parallel suppression (P less than 0.05) of the elevated levels of PRA and PAC in the caval dogs but failed to significantly decrease either PRA or PAC in the normal animals. Arterial pressure, heart rate, and PAH clearance were unchanged in both groups of dogs during infusion of atrial natriuretic factor. These results suggest that the pattern of renal electrolyte excretion elicited in response to the acute infusion of atrial natriuretic factor is dependent, at least partially, on the preexisting status of the renal tubules to facilitate sodium reabsorption and potassium excretion. The results also are consistent with the concept that atrial natriuretic factor might function to tonically inhibit the renin-angiotensin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157329     DOI: 10.1152/ajpregu.1985.248.4.R495

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Biologically active atrial peptides.

Authors:  B J Ballerman; B M Brenner
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  The heart is an endocrine gland.

Authors:  P J Mulrow
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

3.  Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.

Authors:  A Kurtz; R Della Bruna; J Pfeilschifter; R Taugner; C Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure.

Authors:  M R Wilkins; S L Settle; P T Stockmann; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Plasma atrial natriuretic peptide and the renin-aldosterone system during long-term administration of the diuretic xipamide in man.

Authors:  P Lijnen; P Hespel; R Fagard; J Staessen; W Goossens; W Lissens; A Amery
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  The involvement of atriopeptins in blood pressure regulation.

Authors:  B R Cole
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

7.  Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man.

Authors:  J McMurray; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitus.

Authors:  E Jungmann; M C Walter-Schräder; T Haak; W Fassbinder; G Wambach; P H Althoff; K Schöffling
Journal:  Klin Wochenschr       Date:  1988-06-15

Review 9.  Atrial natriuretic factor: physiologic actions and implications in congestive heart failure.

Authors:  B S Edwards; R S Zimmerman; J C Burnett
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

10.  Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.

Authors:  H J Kramer; B Lichardus
Journal:  Klin Wochenschr       Date:  1986-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.